Inkon Life reports increased revenue, board approves no dividend

** INKON Life Technology (SZSE:300143) announced its 2024 financial results, showcasing a 6% increase in revenue, reaching RMB 1.56 billion. Net profit attributable to shareholders also increased by 14.92% to RMB 115.42 million. Despite the improved financials, the board of directors has approved a plan to not distribute a cash dividend or issue bonus shares, citing a negative distributable profit balance of RMB 1.39 billion, which requires shareholders' approval. The last time INKON Life issued a dividend was several years ago. The 2024 total includes $105 million as a result of its non-cash transaction. INKON Life is emphasizing a focus on revenue growth and improved profitability, the main source behind this growth was In conjunction with the financial results, the company announced a series of management actions including $30 million being set aside for an annual equity incentive plans. Also, the management is planning to increase its number of product offerings and international export growth to meet a rising demand for healthcare and medical technology devices. The auditor's report from Hexin Certified Public Accountants has not identified any problems with the 2024 financial report, and was in accordance with standard reporting procedures. These results come at a time when the auditor, Hexin Certified Public Accountants, is looking to increase the number of foreign clients.